Acidic oligosaccharide sugar chain, a marine-derived acidic oligosaccharide, inhibits the cytotoxicity and aggregation of amyloid beta protein

被引:62
作者
Hu, JF
Geng, MY
Li, J
Xin, XL
Wang, J
Tang, MK
Zhang, JT
Zhang, X
Ding, J
机构
[1] Ocean Univ China, Dept Pharmacol, Marine Drug & Food Inst, Qingdao 266003, Peoples R China
[2] Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China
[3] Peking Union Med Coll, Beijing 100050, Peoples R China
[4] Huddinge Univ Hosp, Karolinska Inst, Div Mol Neuropharmacol, Dept Neurotec,Novum KFC, S-14186 Huddinge, Sweden
[5] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
关键词
acidic oligosaccharide sugar chain; amyloid beta protein; neurotoxicity; aggregation;
D O I
10.1254/jphs.FPJ04004X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this paper, we investigated interactions of the acidic oligosaccharide sugar chain (AOSC), derived from brown algae Echlonia kurome OKAM, with amyloid beta protein (Abeta). We observed that AOSC inhibited the toxicity induced by Abeta in both primarily cortical cells and the SH-SY5Y cell line. We also observed that AOSC inhibited the apoptosis induced by Abeta in SH-SY5Y by reducing the elevated level of intracellular calcium concentration ([Ca2+](i)) and suppressing the generation of reactive oxygen species. Surface plasmon resonance analysis demonstrated that AOSC had affinity for both freshly-dissolved Abeta and 48-h incubated Abeta. Furthermore, AOSC blocked the fibril formation of Abeta, which may be responsible for its anti-cytotoxic effects. Thus, our results indicate that AOSC might be a potentially therapeutic compound for Alzheimer's disease.
引用
收藏
页码:248 / 255
页数:8
相关论文
共 30 条
  • [1] Alzheimer's disease:: the pharmacological pathway
    Allain, H
    Bentué-Ferrer, D
    Tribut, O
    Gauthier, S
    Michel, BF
    Drieu-La Rochelle, C
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2003, 17 (04) : 419 - 428
  • [2] RAT HIPPOCAMPAL NEURONS IN DISPERSED CELL-CULTURE
    BANKER, GA
    COWAN, WM
    [J]. BRAIN RESEARCH, 1977, 126 (03) : 397 - 425
  • [3] Alzheimer's disease and oxidative stress: Implications for novel therapeutic approaches
    Behl, C
    [J]. PROGRESS IN NEUROBIOLOGY, 1999, 57 (03) : 301 - 323
  • [4] Heparin attenuates cytotoxic and inflammatory activity of Alzheimer amyloid-β in vitro
    Bergamaschini, L
    Donarini, C
    Rossi, E
    De Luigi, A
    Vergani, C
    De Simoni, MG
    [J]. NEUROBIOLOGY OF AGING, 2002, 23 (04) : 531 - 536
  • [5] Affinity-based inhibition of β-amyloid toxicity
    Cairo, CW
    Strzelec, A
    Murphy, RM
    Kiessling, LL
    [J]. BIOCHEMISTRY, 2002, 41 (27) : 8620 - 8629
  • [6] Amyloid β
    Cappai, R
    White, AR
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1999, 31 (09) : 885 - 889
  • [7] Castillo GM, 1997, J NEUROCHEM, V69, P2452
  • [8] Conlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502
  • [9] Agrin binds to β-amyloid (Aβ), accelerates Aβ fibril formation, and is localized to AB deposits in Alzheimer's disease brain
    Cotman, SL
    Halfter, W
    Cole, GJ
    [J]. MOLECULAR AND CELLULAR NEUROSCIENCE, 2000, 15 (02) : 183 - 198
  • [10] Eckert A, 2003, PHARMACOPSYCHIATRY, V36, pS15